World Journal of Nuclear Medicine

CASE REPORT
Year
: 2012  |  Volume : 11  |  Issue : 1  |  Page : 30--32

Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline


Chjoong Howe Alvin Tan1, Eik Hock Andrew Tan2 
1 Department of Diagnostic Radiology, Khoo Teck Purt Hospital, Singapore
2 Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore

Correspondence Address:
Chjoong Howe Alvin Tan
Department of Diagnostic Radiology, Khoo Teck Puat Hospital, 90 Yishun Central, 768828
Singapore

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a case where various molecular tracers (fluorodeoxyglucose, choline, and methoxyisobutylisonitrile) were used in the post-treatment assessment of a patient with histologically proven GBM.


How to cite this article:
Tan CA, Tan EA. Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline.World J Nucl Med 2012;11:30-32


How to cite this URL:
Tan CA, Tan EA. Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline. World J Nucl Med [serial online] 2012 [cited 2022 Oct 5 ];11:30-32
Available from: http://www.wjnm.org/article.asp?issn=1450-1147;year=2012;volume=11;issue=1;spage=30;epage=32;aulast=Tan;type=0